The association between primary hyperparathyroidism and malignancy: Nationwide cohort analysis on cancer incidence after parathyroidectomy

Endocrine-Related Cancer

Volumn 14, Issue 1, 2007, Pages 135-140

  Nilsson, Inga Lena ^a   Zedenius, Jan ^a   Yin, Li ^a   Ekbom, Anders ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER RISK; CANCER SURGERY; COLON CANCER; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEREDITY; HUMAN; HYPERPARATHYROIDISM; KIDNEY CANCER; MAJOR CLINICAL STUDY; MALE; PANCREAS CANCER; PARATHYROID ADENOMA; PARATHYROIDECTOMY; POPULATION RESEARCH; SEX RATIO; SKIN CANCER; SQUAMOUS CELL CARCINOMA; ADENOMA; COHORT ANALYSIS; INCIDENCE; MIDDLE AGED; NEOPLASM; PARATHYROID TUMOR; PRIMARY HYPERPARATHYROIDISM; SWEDEN;

ADENOMA; ADULT; COHORT STUDIES; FEMALE; HUMANS; HYPERPARATHYROIDISM, PRIMARY; INCIDENCE; MALE; MIDDLE AGED; NEOPLASMS; PARATHYROID NEOPLASMS; SWEDEN;

EID: 34249804523     PISSN: 13510088     EISSN: None     Source Type: Journal    
DOI: 10.1677/erc.1.01261     Document Type: Article

References (31)

1. Backlund LM, Grander D, Brandt L, Hall P & Ekbom A 2005 Parathyroid adenoma and primary CNS tumors. International Journal of Cancer 113 866-869.
2. Bergenfelz A, Lindblom P, Lindergard B, Valdemarsson S & Westerdahl J 2003 Preoperative normal level of parathyroid hormone signifies an early and mild form of primary hyperparathyroidism. World Journal of Surgery 27 481-485.
3. Bianchini F, Kaaks R & Vainio H 2002 Overweight, obesity and cancer risk. Lancet Oncology 3 565-574.
4. Bikle DD, Oda Y & Xie Z 2005 Vitamin D and skin cancer: a problem in gene regulation. Journal of Steroid Biochemistry and Molecular Biology 97 83-91.
5. Bolland MJ, Grey AB, Gamble GD & Reid IR 2004 Association between primary hyperparathyroidism and increased body weight: a meta-analysis. Journal of Clinical Endocrinology and Metabolism 90 1525-1530.
6. Breslow NE & Day N 1987 Statistical Methods in Cancer Research. Lyon: IARC Scientific Publications 82.
7. Carling T, Rastad J, Akerstrom G & Westin G 1998 Vitamin D receptor (VDR) and parathyroid hormone messenger ribonucleic acid levels correspond to polymorphic VDR alleles in human parathyroid tumors. Journal of Clinical Endocrinology and Metabolism 83 2255-2259.
8. Carling T, Rastad J, Szabo E, Westin G & Akerstrom G 2000 Reduced parathyroid vitamin D receptor messenger ribonucleic acid levels in primary and secondary hyperparathyroidism. Journal of Clinical Endocrinology and Metabolism 85 2000-2003.
9. Chen JD, Morrison C, Zhang C, Kahnoski K, Carpten JD & Teh BT 2003 Hyperparathyroidism-jaw tumour syndrome. Journal of Internal Medicine 253 634-642.
10. Dent CE & Watson LCA 1964 Hyperparathyroidism and cancer. British Medical Journal 2 218-221.
11. Fierabracci P, Pinchera A, Miccoli P, Conte PF, Vignali E, Zaccagnini M, Marcocci C & Giani C 2001 Increased prevalence of primary hyperparathyroidism in treated breast cancer. Journal of Endocrinological Investigation 24 315-320.
12. Giovannucci E 2005 The epidemiology of vitamin D and cancer incidence and mortality: a review (United States). Cancer Causes Control 16 83-95.
13. Hagstrom E, Lundgren E, Lithell H, Berglund L, Ljunghall S, Hellman P & Rastad J 2002 Normalized dyslipidaemia after parathyroidectomy in mild primary hyperparathyroidism: population-based study over five years. Clinical Endocrinology 56 253-260.
14. Hedback G & Oden A 2003 Recurrence of hyperparathyroidism; a long-term follow-up after surgery for primary hyperparathyroidism. European Journal of Endocrinology 148 413-421.
15. Hedback G, Tisell LE, Bengtsson BÅ, Hedman I & Oden A 1990 Premature death in patients operated on for primary hyperparathyroidism. World Journal of Surgery 14 829-836.
16. Hedback G, Oden A & Tisell LE 1995 Parathyroid adenoma weight and the risk of death after treatment for primary hyperparathyroidism. Surgery 117 134-139.
17. Hickey RC, Jung PJ, Merrel R, Ordonez N & Samaan NA 1991 Parathyroid adenoma in a cancer center population. American Journal of Surgery 161 439-442.
18. Katz A, Kaplan L, Massry SG, Heller R, Plotkin D & Knight I 1970 Primary hyperparathyroidism in patients with breast carcinoma. Archives of Surgery 101 582-585.
19. Koch CA, Huang SC, Moley JF, Azumi N, Chrousos GP, Gagel RF, Zhuang Z, Pacak K & Vortmeyer AO 2001 Allelic imbalance of the mutant and wild-type RET allele in MEN 2A-associated medullary thyroid carcinoma. Oncogene 20 7809-7811.
20. Lundgren E, Rastad J, Thurfjell E, Akerstrom G & Ljunghall S 1997 Population-based screening for primary hyperparathyroidism with serum calcium and parathyroid hormone values in menopausal women. Surgery 121 287-294.
21. Mattsson B & Wallgren A 1984 Completeness of the Swedish cancer register. Non-notified cancer cases recorded on death certificates in 1978. Acta Radiologica Oncology 23 305-313.
22. Michels KB, Xue F, Brandt L & Ekbom A 2004 Hyperparathyroidism and subsequent incidence of breast cancer. International Journal of Cancer 110 449-451.
23. Nilsson IL, Wadsten C, Brandt L, Rastad J & Ekbom A 2004 Mortality in sporadic primary hyperparathyroidism: nationwide cohort study of multiple parathyroid gland disease. Surgery 5 981-987.
24. Palmer M, Ljunghall S, Akerstrom G, Adami HO, Bergstrom R, Grimelius L, Rudberg C & Johansson H 1987 Patients with primary hyperparathyroidism operated on over a 24-year period: temporal trends of clinical and laboratory findings. Journal of Chronic Diseases 40 121-130.
25. Palmer M, Adami HO, Krusemo UB & Ljunghall S 1988 Increased risk of malignant diseases after surgery for primary hyperparathyroidism. A nationwide cohort study. American Journal of Epidemiology 127 1031-1040.
26. Pickard AL, Gridley G, Mellemkjs L, Johansen C, Kofoed-Enevoldsen A, Cantor K & Brinton L 2002 Hyperparathyroidism and subsequent cancer risk in Denmark. Cancer 95 1611-1617.
27. Samaan NA, Hickey RC, Sethi MR, Yang KP & Wallace S 1976 Hypercalcemia in patients with known malignent disease. Surgery 80 382-389.
28. Skogseid B 2003 Multiple endocrine neoplasia type 1. British Journal of Surgery 90 383-385.
29. Soreide JA, van Heerden JA, Grant CS, Yau Lo C, Schleck C & Ilstrup DM 1997 Survival after surgical treatment for primary hyperparathyroidism. Surgery 122 1117-1123.
30. Valdemarsson S, Lindergard B, Tibblin S & Bergenfelz A 1998 Increased biochemical markers of bone formation and resorption in primary hyperparathyroidism with special reference to patients with mild disease. Journal of Internal Medicine 243 115-122.
31. Wermers RA, Khosla S, Atkinson E, Grant C, Hodgson S, O'Fallon M & Melton J 1998 Survival after the diagnosis of hyperparathyroidism: a population-based study. American Journal of Medicine 104 115-122.